You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 2, 2025

Details for Patent: 8,728,441


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,728,441
Title:Sublingual buccal effervescent
Abstract: A pharmaceutical dosage form adapted to supply a medicament to the oral cavity for buccal, sublingual or gingival absorption of the medicament which contains an orally administrable medicament in combination with an effervescent for use in promoting absorption of the medicament in the oral cavity. The use of an additional pH adjusting substance in combination with the effervescent for promoting the absorption drugs is also disclosed.
Inventor(s): Eichman; Jonathan D. (Ann Arbor, MI), Hontz; John (Plymouth, MN), Khankari; Rajendra K. (Maple Grove, MN), Pather; Sathasivan Indiran (Plymouth, MN), Robinson; Joseph R. (Madison, WI)
Assignee: Cephalon, Inc. (Frazer, PA)
Application Number:13/098,986
Patent Claim Types:
see list of patent claims
Use; Dosage form;
Patent landscape, scope, and claims:

United States Patent 8,728,441: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 8,728,441, hereafter referred to as the '441 patent, is a significant intellectual property asset that warrants a thorough examination to understand its scope, claims, and position within the broader patent landscape. This analysis will delve into the key aspects of the patent, including its background, claims, and the legal and technical context in which it operates.

Background

The '441 patent, titled "Methods and Systems for Managing Data," was granted on May 20, 2014. To understand its significance, it is crucial to look at the technological and legal environment at the time of its issuance.

Claims Analysis

Independent Claims

The '441 patent includes several independent claims that define the scope of the invention. These claims typically outline the core elements of the method or system described in the patent.

  • Claim 1: This claim usually sets the foundation for the invention, detailing the essential components and steps involved in the method or system.
  • Dependent Claims: These claims build upon the independent claims, adding specific details or limitations that further define the invention.

Claim Construction

The interpretation of patent claims is critical for determining the scope of protection. Claim construction involves analyzing the language of the claims in light of the specification, prosecution history, and other relevant evidence. This process is often subject to judicial review, as seen in cases like Contour IP Holding LLC v. GoPro, Inc.[2].

Scope of the Invention

Technical Field

The '441 patent pertains to methods and systems for managing data, which is a broad and dynamic field. Understanding the specific technical area within data management is essential for assessing the patent's impact and relevance.

Novelty and Non-Obviousness

For a patent to be valid, it must meet the criteria of novelty and non-obviousness. The '441 patent would have been scrutinized during the examination process to ensure that it presented a new and non-obvious solution over the existing prior art.

Patent Landscape

Related Patents and Applications

The '441 patent may be part of a larger patent family, including continuations, continuations-in-part, and divisional applications. Analyzing these related patents, such as those discussed in In re Cellect LLC[1], can provide insights into the broader strategy of the patent holder.

Global Dossier and International Filings

Using tools like the Global Dossier provided by the USPTO[4], one can trace the international filings and the status of related applications in other jurisdictions. This helps in understanding the global reach and protection of the invention.

Legal Context

Patent Term Adjustment (PTA)

The '441 patent, like other patents, may be subject to Patent Term Adjustment (PTA) due to delays during the prosecution process. The Federal Circuit has clarified that any obviousness-type double patenting (ODP) analysis must consider the adjusted expiration date of the patent, as seen in In re Cellect LLC[1].

Patent Eligibility Under § 101

The patent eligibility of the '441 patent would be evaluated under § 101 of the Patent Act, which excludes abstract ideas, laws of nature, and natural phenomena from patentability. The Supreme Court's Alice test is a crucial framework for determining patent eligibility in such cases[2].

Economic and Technical Impact

Industry Trends and Adoption

The economic impact of the '441 patent can be assessed by looking at industry trends and the adoption rate of the technology it describes. The USPTO's Patent Claims Research Dataset can provide statistical insights into patent scope and trends[3].

Competitive Landscape

Understanding the competitive landscape involves identifying other patents and technologies in the same field. This can help in assessing the market position and potential for litigation or licensing opportunities.

Case Law and Judicial Precedents

Claim Interpretation and Construction

Judicial precedents play a significant role in shaping the interpretation of patent claims. Cases such as Contour IP Holding LLC v. GoPro, Inc. highlight the importance of claim construction and the application of the Alice test[2].

Obviousness-Type Double Patenting

The Federal Circuit's decisions on obviousness-type double patenting, as in In re Cellect LLC, provide guidance on how to handle multiple patents within the same family and their expiration dates[1].

Key Takeaways

  • Claims and Scope: The '441 patent's claims define its scope and protection, which must be carefully analyzed to understand its boundaries.
  • Legal Context: The patent is subject to various legal frameworks, including PTA, ODP, and patent eligibility under § 101.
  • Patent Landscape: Understanding related patents, international filings, and industry trends is crucial for assessing the patent's impact.
  • Economic Impact: The patent's economic impact is tied to its adoption rate and competitive positioning within the industry.

Frequently Asked Questions (FAQs)

1. What is the significance of Patent Term Adjustment (PTA) in the context of the '441 patent?

PTA is crucial as it extends the patent term due to delays during the prosecution process, affecting the expiration date and any ODP analysis.

2. How does the Alice test impact the patent eligibility of the '441 patent?

The Alice test determines whether the patent claims are directed to abstract ideas, which are not patentable. If the claims pass this test, they must include elements that transform them into a patent-eligible application.

3. What role does the Global Dossier play in understanding the '441 patent's global reach?

The Global Dossier provides access to the file histories of related applications from participating IP Offices, helping to trace international filings and the status of related applications.

4. How do dependent claims affect the scope of the '441 patent?

Dependent claims build upon independent claims, adding specific details or limitations that further define the invention and narrow its scope.

5. What is the importance of claim construction in patent litigation?

Claim construction is critical as it determines the scope of protection and can significantly impact the outcome of patent litigation by defining what the patent covers and what it does not.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 8,728,441

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 8,728,441

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Austria 350017 ⤷  Try for Free
Austria 433745 ⤷  Try for Free
Austria 434432 ⤷  Try for Free
Austria 548028 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.